MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC Meeting Abstract


Authors: Caeser, R.; Hulton, C.; Durani, V.; Costa, E.; Little, M.; Shah, N. S.; de Stanchina, E.; Poirier, J. T.; Rudin, C. M.; Sen, T.
Abstract Title: MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC
Meeting Title: 112th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 81
Issue: 13 Suppl.
Meeting Dates: 2021 Apr 10-15/May 17-21
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-07-01
Language: English
ACCESSION: WOS:000680263501093
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2021-LB186
Notes: Meeting Abstract: LB186 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles Rudin
    488 Rudin
  2. Nisargbhai Sanjaykumar Shah
    29 Shah
  3. Vidushi Durani
    12 Durani
  4. Christopher Hulton
    7 Hulton
  5. Triparna Sen
    56 Sen
  6. Megan Little
    5 Little
  7. Rebecca Caeser
    14 Caeser
  8. Emily Costa
    4 Costa